CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 4, Randomized, Double-masked, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of TEPEZZA® in Treating Patients With Chronic (Inactive) Thyroid Eye Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04583735
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:25.077525+00:00
Published At: 2024-04-26T00:00:00+00:00
Record Updated At: 2024-07-01
Results Posted At: 2024-04-26
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Thyroid Eye Disease", "Chronic (Inactive) Thyroid Eye Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-07-01"
protocolSection.identificationModule.nctId: "NCT04583735"
protocolSection.identificationModule.officialTitle: "A Phase 4, Randomized, Double-masked, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of TEPEZZA\u00ae in Treating Patients With Chronic (Inactive) Thyroid Eye Disease"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2024-04-26"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.